An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe

Primary tumor type prediction based on US nationwide genomic profiling data in 13,522 patients - ScienceDirect

Social determinants of health and survival on Brazilian patients with glioblastoma: a retrospective analysis of a large populational database - The Lancet Regional Health – Americas

A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma - ScienceDirect

Real-World Outcomes with Chimeric Antigen Receptor T Cell Therapies in Large B Cell Lymphoma: A Systematic Review and Meta-Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy - Cytotherapy

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis - ScienceDirect

Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study - ScienceDirect

Validation of the Social Security Administration Life Tables (2004–2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database - European Urology Focus

Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101 - Transplantation and Cellular Therapy, Official Publication of the

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study - The Lancet Oncology